article thumbnail

New analysis supports use of FES-PET in breast cancer patients

AuntMinnie

F-18 fluoroestradiol (FES)-PET scans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine.

PET Scan 227
article thumbnail

FES-PET shows promise staging patients with low-grade breast cancer

AuntMinnie

Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PET scans.

PET Scan 283
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IMV: PET scan volumes continue to grow

AuntMinnie

In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, the average number of PET scans per fixed PET site (versus mobile PET) increased 6.7%

PET Scan 290
article thumbnail

IMV: PET procedure volumes continue strong growth trend

AuntMinnie

Over the same period between the two years, the average number of PET scans performed per installed fixed PET/CT systems increased by 8.2% -- a finding that indicates that much of the increased procedure volumes have been absorbed by existing PET system capacity. Davin Korstjens of IMV Medical Information Division.

PET Scan 162
article thumbnail

PET scan times can be reduced in Alzheimer’s patients

AuntMinnie

F-18 florbetaben PET scans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PET imaging in clinical settings,” the group wrote.

PET Scan 203
article thumbnail

CMS lifts limit on amyloid PET coverage

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PET scan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PET scans will now be made by local Medicare Administrative Contractors (MACs).

article thumbnail

PET reveals ‘smoldering’ brain inflammation in patients treated for MS

AuntMinnie

In a study published April 17 in Clinical Nuclear Medicine , the group at Brigham tested a new TSPO radiotracer they developed for visualizing such activity called F-18 PBR06. The researchers performed F-18 PBR06 PET scans on 22 patients with MS and eight healthy controls. Image courtesy of Clinical Nuclear Medicine.

PET Scan 306